Loratadine liquid composition
A technology of loratadine and composition, which is applied in the directions of drug combination, drug delivery, medical preparations of inactive ingredients, etc., can solve problems such as tediousness
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Publication Date
- 2015-09-30
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of medicines, and relates to an oil-based pharmaceutical composition, in particular to an oil-based oil pharmaceutical composition of loratadine which can be used orally. The present invention further relates to a preparation method for preparing the liquid oil pharmaceutical composition of the present invention. Background technique
[0002] Loratadine (Loratadine), chemical name: 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridine-11-ylidene Base)-1-piperidinecarboxylate ethyl ester, 4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1- piperidinecarboxylic acid ethyl ester, molecular formula: C22H23ClN2O2, molecular weight: 382.89, structural formula:
[0003]
[0004] Loratadine is a white or off-white crystalline powder, odorless. Loratadine is easily soluble in methanol, ethanol or acetone, slightly soluble in 0.1mol / L hydrochloric acid solution, and almost ins...
Examples
Embodiment A1
[0112] Embodiment A1: Preparation of the composition of the present invention
[0113] Prescription (prepared in 1000 servings, the prescription for each serving is as follows):
[0114]
[0115] Preparation method: take loratadine, add about 90% of the formula oil, stir to dissolve, add oil to the full amount, and stir evenly to obtain the composition of the present invention, which is a transparent liquid without sediment.
[0116] Half of the liquid medicine of the present embodiment composition prepared above is packed in a glass bottle (also can be a plastic bottle such as a high-density polyethylene bottle), and the other half is prepared into a soft capsule preparation as follows:
[0117] Capsule skin formula: 40% gelatin, 18% glycerin, 7% sorbitol, 35% water.
[0118] By the following steps, the above-mentioned liquid composition of the present invention is wrapped in prepared capsule skins, and each capsule contains 10 mg of active ingredient.
[0119] Take gel...
Embodiment A2
[0120] Embodiment A2: Preparation of the composition of the present invention
[0121] Prescription (prepared in 1000 servings, the prescription for each serving is as follows):
[0122]
[0123] Preparation method: Prepare according to the method of Example A1 to obtain the composition of the present invention. Further, a part of the composition is packaged in a glass bottle, and the other part is prepared into a soft capsule preparation.
Embodiment A3
[0124] Embodiment A3: Preparation of the composition of the present invention
[0125] Prescription (prepared in 1000 servings, the prescription for each serving is as follows):
[0126]
[0127] Preparation method: Prepare according to the method of Example A1 to obtain the composition of the present invention. Further, a part of the composition is packaged in a glass bottle, and the other part is prepared into a soft capsule preparation.